Archives of Clinical Infectious Diseases

Published by: Kowsar
Uncorrected Proof scheduled for 14 (3)

The Relationship Between Serum IL-17 Level and Viral Load in Chronic Hepatitis B

Maliheh Metanat 1 , * , Ebrahim Alijani 2 , Alireza Ansari-Moghaddam ORCID 3 , Fatemeh Bahrehmand 1 , Manijeh Khalili 4 , Narges Arbabi 1 , Soheila Khosravi 5 , Esmaeil Sanei Moghadam 5 and Roya Alavi-Naini 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
2 Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
3 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
4 Children and Adolescents Health Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran
5 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Zahedan, Iran
Article information
  • Archives of Clinical Infectious Diseases: In Press (In Press); e68172
  • Published Online: June 11, 2019
  • Article Type: Research Article
  • Received: March 2, 2018
  • Revised: February 27, 2019
  • Accepted: March 10, 2019
  • DOI: 10.5812/archcid.68172

To Cite: Metanat M, Alijani E, Ansari-Moghaddam A , Bahrehmand F , Khalili M, et al. The Relationship Between Serum IL-17 Level and Viral Load in Chronic Hepatitis B, Arch Clin Infect Dis. Online ahead of Print ; In Press(In Press):e68172. doi: 10.5812/archcid.68172.

Copyright © 2019, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Gerlich WH, Bremer C, Saniewski M, Schuttler CG, Wend UC, Willems WR, et al. Occult hepatitis B virus infection: Detection and significance. Dig Dis. 2010;28(1):116-25. doi: 10.1159/000282074. [PubMed: 20460899].
  • 2. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: An update for clinicians. Mayo Clin Proc. 2007;82(8):967-75. doi: 10.4065/82.8.967. [PubMed: 17673066].
  • 3. Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B virus infection in the general population of Iran: An updated systematic review and meta-analysis. Hepatitis Monthly. 2016;16(4). doi: 10.5812/hepatmon.35577.
  • 4. Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev. 2007;20(3):426-39. table of contents. doi: 10.1128/CMR.00009-07. [PubMed: 17630333]. [PubMed Central: PMC1932755].
  • 5. Lok AS, Conjeevaram HS. Hepatitis B. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. 1. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003.
  • 6. Mohamed AA, Nada OH, El Desouky MA. Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis. Diagn Pathol. 2012;7:103. doi: 10.1186/1746-1596-7-103. [PubMed: 22894766]. [PubMed Central: PMC3487824].
  • 7. Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H, Hashemi M, Metanat M, Khosravi S, et al. Association between IL-10 gene promoter polymorphisms (-592 A/C, -819 T/C, -1082 A/G) and susceptibility to HBV infection in an Iranian population. Hepat Mon. 2016;16(2). e32427. doi: 10.5812/hepatmon.32427. [PubMed: 27148384]. [PubMed Central: PMC4852092].
  • 8. Iannacone M, Sitia G, Isogawa M, Marchese P, Castro MG, Lowenstein PR, et al. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med. 2005;11(11):1167-9. doi: 10.1038/nm1317. [PubMed: 16258538]. [PubMed Central: PMC2908083].
  • 9. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52(1):65-70. doi: 10.1136/gut.52.1.65. [PubMed: 12477762]. [PubMed Central: PMC1773503].
  • 10. Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, et al. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Intervirology. 2008;51(5):352-61. doi: 10.1159/000187720. [PubMed: 19127078].
  • 11. Romagnani S. Human Th17 cells. Arthritis Res Ther. 2008;10(2):206. doi: 10.1186/ar2392. [PubMed: 18466633]. [PubMed Central: PMC2453756].
  • 12. Gaffen SL. An overview of IL-17 function and signaling. Cytokine. 2008;43(3):402-7. doi: 10.1016/j.cyto.2008.07.017. [PubMed: 18701318]. [PubMed Central: PMC2582446].
  • 13. Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, Kilpatrick L, et al. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. 2008;10(6):R95. doi: 10.1186/bcr2195. [PubMed: 19014637]. [PubMed Central: PMC2656888].
  • 14. Kozlowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst. 2003;48:82-4. [PubMed: 14737948].
  • 15. Zamani B, Moraveji SA, Ehteram H, Shikrani M. [Correlation between the serum level of IL-17 and rheumatoid arthritis]. J Kashan Univ Med Sci. 2015;19(1):47-53. Persian.
  • 16. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol. 2008;20(5):519-25. doi: 10.1097/BOR.0b013e328304b6b5. [PubMed: 18698171].
  • 17. Maloy KJ. The Interleukin-23 / Interleukin-17 axis in intestinal inflammation. J Intern Med. 2008;263(6):584-90. doi: 10.1111/j.1365-2796.2008.01950.x. [PubMed: 18479257].
  • 18. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol. 2008;181(9):6117-24. doi: 10.4049/jimmunol.181.9.6117. [PubMed: 18941201].
  • 19. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol. 2005;175(6):3920-6. doi: 10.4049/jimmunol.175.6.3920. [PubMed: 16148138].
  • 20. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol. 2007;37(10):2695-706. doi: 10.1002/eji.200737409. [PubMed: 17899546].
  • 21. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24(2):179-89. doi: 10.1016/j.immuni.2006.01.001. [PubMed: 16473830].
  • 22. Wang L, Chen S, Xu K. IL-17 expression is correlated with hepatitis Brelated liver diseases and fibrosis. Int J Mol Med. 2011;27(3):385-92. doi: 10.3892/ijmm.2011.594. [PubMed: 21225222].
  • 23. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81-91. doi: 10.1002/hep.23273. [PubMed: 19842207].
  • 24. Shi M, Wei J, Dong J, Meng W, Ma J, Wang T, et al. Function of interleukin-17 and -35 in the blood of patients with hepatitis B-related liver cirrhosis. Mol Med Rep. 2015;11(1):121-6. doi: 10.3892/mmr.2014.2681. [PubMed: 25323532]. [PubMed Central: PMC4237084].
  • 25. Xu Y, Du WJ, Qin LY, Xing ZZ, Qin XH, Chen SJ. [Expression of interleukin-17 in hepatitis B related liver fibrosis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009;25(2):133-5. Chinese. [PubMed: 19174010].
  • 26. Du WJ, Zhen JH, Zeng ZQ, Zheng ZM, Xu Y, Qin LY, et al. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection. Diagn Pathol. 2013;8:40. doi: 10.1186/1746-1596-8-40. [PubMed: 23448394]. [PubMed Central: PMC3598543].
  • 27. Feng H, Yin J, Han YP, Zhou XY, Chen S, Yang L, et al. Regulatory T cells and IL-17(+) T helper cells enhanced in patients with chronic hepatitis B virus infection. Int J Clin Exp Med. 2015;8(6):8674-85. [PubMed: 26309519]. [PubMed Central: PMC4538083].
  • 28. El-Gazzar AA, El-Basuoni MA, Soliman MA, Zaghla HE, Allam MM. Interleukin-17-producing CD4+T cells in patients with chronic hepatitis B. Menoufia Medical Journal. 2014;27(4):775. doi: 10.4103/1110-2098.149753.
  • 29. Yu X, Guo R, Ming D, Deng Y, Su M, Lin C, et al. The transforming growth factor beta1/Interleukin-31 pathway is upregulated in patients with hepatitis B virus-related acute-on-chronic liver failure and is associated with disease severity and survival. Clin Vaccine Immunol. 2015;22(5):484-92. doi: 10.1128/CVI.00649-14. [PubMed: 25716231]. [PubMed Central: PMC4412936].
  • 30. Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010;25(4):750-7. doi: 10.1111/j.1440-1746.2009.06154.x. [PubMed: 20492330].
  • 31. Meng P, Zhao S, Niu X, Fu N, Su S, Wang R, et al. Involvement of the Interleukin-23/Interleukin-17 axis in chronic hepatitis C virus infection and its treatment responses. Int J Mol Sci. 2016;17(7). doi: 10.3390/ijms17071070. [PubMed: 27428948]. [PubMed Central: PMC4964446].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments